To Fulfill the Clinical Requirements with Innovative Technologies

To Improve the Well-being of Humans with a Cautious Attitude Towards Life

Established in 2012, with headquarter in Suzhou, Peijia Medical Limited focuses on the high-growth interventional procedural medical device market in China, and aims to become a world-renowned medical device platform that provides total treatment solutions for structural heart and neurovascular diseases. The Company was listed on The Stock Exchange of Hong Kong Limited in May 2020 under the stock code of 9996.